Evolution of sequential bortezomib-dexamethasone treatment followed by autologous hematopoietic stem cell transplantation in hemodialysis treatment

被引:0
|
作者
Li Cavoli Gioacchino [1 ]
Zagarrigo Carmela [1 ]
Servillo Franca [1 ]
Coglitore Mario [1 ]
Schillaci Onofrio [1 ]
Tralongo Angelo [1 ]
Rotolo Ugo [1 ]
机构
[1] Nephrology and Dialysis,Civic and Di Cristina Hospital
关键词
D O I
暂无
中图分类号
R457 [血液疗法];
学科分类号
100215 ;
摘要
To the editor:We read with interest the article of Zheng et al~1on sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation(ASCT)in patients with multiple myeloma(MM).
引用
收藏
页码:1795 / 1795
相关论文
共 50 条
  • [41] Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma
    Moreau, Philippe
    Avet-Loiseau, Herve
    Facon, Thierry
    Attal, Michel
    Tiab, Mourad
    Hulin, Cyrille
    Doyen, Chantal
    Garderet, Laurent
    Randriamalala, Edouard
    Araujo, Carla
    Lepeu, Gerard
    Marit, Gerald
    Caillot, Denis
    Escoffre, Martine
    Lioure, Bruno
    Benboubker, Lotfi
    Pegourie, Brigitte
    Kolb, Brigitte
    Stoppa, Anne Marie
    Fuzibet, Jean-Gabriel
    Decaux, Olivier
    Dib, Mamoun
    Berthou, Christian
    Chaleteix, Carine
    Sebban, Catherine
    Traulle, Catherine
    Fontan, Jean
    Wetterwald, Marc
    Lenain, Pascal
    Mathiot, Claire
    Harousseau, Jean-Luc
    BLOOD, 2011, 118 (22) : 5752 - 5758
  • [42] Determining the optimal time for bortezomib-based induction chemotherapy followed by autologous hematopoietic stem cell transplant in the treatment of multiple myeloma
    Junru Liu
    Juan Li
    Beihui Huang
    Dong Zheng
    Mei Chen
    Zhenhai Zhou
    Duorong Xu
    Waiyi Zou
    ChineseJournalofCancerResearch, 2013, 25 (02) : 166 - 174
  • [43] Determining the optimal time for bortezomib-based induction chemotherapy followed by autologous hematopoietic stem cell transplant in the treatment of multiple myeloma
    Liu, Junru
    Li, Juan
    Huang, Beihui
    Zheng, Dong
    Chen, Mei
    Zhou, Zhenhai
    Xu, Duorong
    Zou, Waiyi
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (02) : 166 - 174
  • [44] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION AS FIRST LINE TREATMENT IN MULTIPLE MYELOMA. SINGLE CENTER EXPERIENCE
    Arguinano, J. M.
    Zudaire, M.
    Pena, E.
    Aoiz, I.
    Hamdi, M.
    Mateos, M.
    Ardaiz, M.
    Viguria, M.
    Rodriguez Calvillo, M.
    Gorosquieta, A.
    Sanchez Anton, M.
    Quispe, I.
    Arregui, P.
    Montoya, M.
    Garcia Ramirez, P.
    Alvarellos, M.
    HAEMATOLOGICA, 2015, 100 : 735 - 735
  • [45] Reduction of Optic Disc Oedema by Bortezomib and Dexamethasone Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patient with POEMS Syndrome
    Iwase, Takehito
    Yokouchi, Hirotaka
    Misawa, Sonoko
    Oshitari, Toshiyuki
    Baba, Takayuki
    Kuwabara, Satoshi
    Yamamoto, Shuichi
    NEURO-OPHTHALMOLOGY, 2018, 42 (01) : 25 - 30
  • [46] Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT
    Livio Pagano
    Alessio Maria Edoardo Maraglino
    Luana Fianchi
    Marianna Criscuolo
    Elena Rossi
    Tommaso Za
    Patrizia Chiusolo
    Matteo Bonanni
    Giulia Dragonetti
    Andrea Bacigalupo
    Simona Sica
    Valerio De Stefano
    Annals of Hematology, 2020, 99 : 207 - 209
  • [47] Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT
    Pagano, Livio
    Maraglino, Alessio Maria Edoardo
    Fianchi, Luana
    Criscuolo, Marianna
    Rossi, Elena
    Za, Tommaso
    Chiusolo, Patrizia
    Bonanni, Matteo
    Dragonetti, Giulia
    Bacigalupo, Andrea
    Sica, Simona
    De Stefano, Valerio
    ANNALS OF HEMATOLOGY, 2020, 99 (01) : 207 - 209
  • [48] Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment
    Orrantia, Ane
    Terren, Inigo
    Astarloa-Pando, Gabirel
    Zenarruzabeitia, Olatz
    Borrego, Francisco
    CANCERS, 2021, 13 (07)
  • [49] Autologous Hematopoietic Stem Cell Transplantation as a Treatment Option for Aggressive Multiple Sclerosis
    Pfender, Nikolai
    Saccardi, Riccardo
    Martin, Roland
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2013, 15 (03) : 270 - 280
  • [50] Updated views on autologous hematopoietic stem cell transplantation for treatment of multiple sclerosis
    Sormani, Maria Pia
    Muraro, Paolo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 469 - 470